[1]
Sandler, R.S. Epidemiology of inflammatory bowel disease. Inflammatory Bowel Disease. From Bench to Bedside; Targan, S.R; Shanahan, F., Ed.; Williams & Wilkins: Baltimore, 1994, pp. 5-31.
[2]
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2015, 386(9995), 743-800.
[3]
Murray, C.J.; Barber, R.M.; Foreman, K.J.; Abbasoglu Ozgoren, A.; Abd-Allah, F.; Abera, S.F.; Aboyans, V.; Abraham, J.P.; Abubakar, I.; Abu-Raddad, L.J.; Abu-Rmeileh, N.M.; Achoki, T.; Ackerman, I.N.; Ademi, Z.; Adou, A.K.; Adsuar, J.C.; Afshin, A.; Agardh, E.E.; Alam, S.S.; Alasfoor, D.; Albittar, M.I.; Alegretti, M.A.; Alemu, Z.A.; Alfonso-Cristancho, R.; Alhabib, S.; Ali, R.; Alla, F.; Allebeck, P.; Almazroa, M.A.; Alsharif, U.; Alvarez, E.; Alvis-Guzman, N.; Amare, A.T.; Ameh, E.A.; Amini, H.; Ammar, W.; Anderson, H.R.; Anderson, B.O.; Antonio, C.A.; Anwari, P.; Arnlöv, J.; Arsic Arsenijevic, V.S.; Artaman, A.; Asghar, R.J.; Assadi, R.; Atkins, L.S.; Avila, M.A.; Awuah, B.; Bachman, V.F.; Badawi, A.; Bahit, M.C.; Balakrishnan, K.; Banerjee, A.; Barker-Collo, S.L.; Barquera, S.; Barregard, L.; Barrero, L.H.; Basu, A.; Basu, S.; Basulaiman, M.O.; Beardsley, J.; Bedi, N.; Beghi, E.; Bekele, T.; Bell, M.L.; Benjet, C.; Bennett, D.A.; Bensenor, I.M.; Benzian, H.; Bernabé, E.; Bertozzi-Villa, A.; Beyene, T.J.; Bhala, N.; Bhalla, A.; Bhutta, Z.A.; Bienhoff, K.; Bikbov, B.; Biryukov, S.; Blore, J.D.; Blosser, C.D.; Blyth, F.M.; Bohensky, M.A.; Bolliger, I.W.; Bora Başara, B.; Bornstein, N.M.; Bose, D.; Boufous, S.; Bourne, R.R.; Boyers, L.N.; Brainin, M.; Brayne, C.E.; Brazinova, A.; Breitborde, N.J.; Brenner, H.; Briggs, A.D.; Brooks, P.M.; Brown, J.C.; Brugha, T.S.; Buchbinder, R.; Buckle, G.C.; Budke, C.M.; Bulchis, A.; Bulloch, A.G.; Campos-Nonato, I.R.; Carabin, H.; Carapetis, J.R.; Cárdenas, R.; Carpenter, D.O.; Caso, V.; Castañeda-Orjuela, C.A.; Castro, R.E.; Catalá-López, F.; Cavalleri, F.; Çavlin, A.; Chadha, V.K.; Chang, J.C.; Charlson, F.J.; Chen, H.; Chen, W.; Chiang, P.P.; Chimed-Ochir, O.; Chowdhury, R.; Christensen, H.; Christophi, C.A.; Cirillo, M.; Coates, M.M.; Coffeng, L.E.; Coggeshall, M.S.; Colistro, V.; Colquhoun, S.M.; Cooke, G.S.; Cooper, C.; Cooper, L.T.; Coppola, L.M.; Cortinovis, M.; Criqui, M.H.; Crump, J.A.; Cuevas-Nasu, L.; Danawi, H.; Dandona, L.; Dandona, R.; Dansereau, E.; Dargan, P.I.; Davey, G.; Davis, A.; Davitoiu, D.V.; Dayama, A.; De Leo, D.; Degenhardt, L.; Del Pozo-Cruz, B.; Dellavalle, R.P.; Deribe, K.; Derrett, S.; Des Jarlais, D.C.; Dessalegn, M.; Dharmaratne, S.D.; Dherani, M.K.; Diaz-Torné, C.; Dicker, D.; Ding, E.L.; Dokova, K.; Dorsey, E.R.; Driscoll, T.R.; Duan, L.; Duber, H.C.; Ebel, B.E.; Edmond, K.M.; Elshrek, Y.M.; Endres, M.; Ermakov, S.P.; Erskine, H.E.; Eshrati, B.; Esteghamati, A.; Estep, K.; Faraon, E.J.; Farzadfar, F.; Fay, D.F.; Feigin, V.L.; Felson, D.T.; Fereshtehnejad, S.M.; Fernandes, J.G.; Ferrari, A.J.; Fitzmaurice, C.; Flaxman, A.D.; Fleming, T.D.; Foigt, N.; Forouzanfar, M.H.; Fowkes, F.G.; Paleo, U.F.; Franklin, R.C.; Fürst, T.; Gabbe, B.; Gaffikin, L.; Gankpé, F.G.; Geleijnse, J.M.; Gessner, B.D.; Gething, P.; Gibney, K.B.; Giroud, M.; Giussani, G.; Gomez Dantes, H.; Gona, P.; González-Medina, D.; Gosselin, R.A.; Gotay, C.C.; Goto, A.; Gouda, H.N.; Graetz, N.; Gugnani, H.C.; Gupta, R.; Gupta, R.; Gutiérrez, R.A.; Haagsma, J.; Hafezi-Nejad, N.; Hagan, H.; Halasa, Y.A.; Hamadeh, R.R.; Hamavid, H.; Hammami, M.; Hancock, J.; Hankey, G.J.; Hansen, G.M.; Hao, Y.; Harb, H.L.; Haro, J.M.; Havmoeller, R.; Hay, S.I.; Hay, R.J.; Heredia-Pi, I.B.; Heuton, K.R.; Heydarpour, P.; Higashi, H.; Hijar, M.; Hoek, H.W.; Hoffman, H.J.; Hosgood, H.D.; Hossain, M.; Hotez, P.J.; Hoy, D.G.; Hsairi, M.; Hu, G.; Huang, C.; Huang, J.J.; Husseini, A.; Huynh, C.; Iannarone, M.L.; Iburg, K.M.; Innos, K.; Inoue, M.; Islami, F.; Jacobsen, K.H.; Jarvis, D.L.; Jassal, S.K.; Jee, S.H.; Jeemon, P.; Jensen, P.N.; Jha, V.; Jiang, G.; Jiang, Y.; Jonas, J.B.; Juel, K.; Kan, H.; Karch, A.; Karema, C.K.; Karimkhani, C.; Karthikeyan, G.; Kassebaum, N.J.; Kaul, A.; Kawakami, N.; Kazanjan, K.; Kemp, A.H.; Kengne, A.P.; Keren, A.; Khader, Y.S.; Khalifa, S.E.; Khan, E.A.; Khan, G.; Khang, Y.H.; Kieling, C.; Kim, D.; Kim, S.; Kim, Y.; Kinfu, Y.; Kinge, J.M.; Kivipelto, M.; Knibbs, L.D.; Knudsen, A.K.; Kokubo, Y.; Kosen, S.; Krishnaswami, S. Kuate Defo, B.; Kucuk Bicer, B.; Kuipers, E.J.; Kulkarni, C.; Kulkarni, V.S.; Kumar, G.A.; Kyu, H.H.; Lai, T.; Lalloo, R.; Lallukka, T.; Lam, H.; Lan, Q.; Lansingh, V.C.; Larsson, A.; Lawrynowicz, A.E.; Leasher, J.L.; Leigh, J.; Leung, R.; Levitz, C.E.; Li, B.; Li, Y.; Li, Y.; Lim, S.S.; Lind, M.; Lipshultz, S.E.; Liu, S.; Liu, Y.; Lloyd, B.K.; Lofgren, K.T.; Logroscino, G.; Looker, K.J.; Lortet-Tieulent, J.; Lotufo, P.A.; Lozano, R.; Lucas, R.M.; Lunevicius, R.; Lyons, R.A.; Ma, S.; Macintyre, M.F.; Mackay, M.T.; Majdan, M.; Malekzadeh, R.; Marcenes, W.; Margolis, D.J.; Margono, C.; Marzan, M.B.; Masci, J.R.; Mashal, M.T.; Matzopoulos, R.; Mayosi, B.M.; Mazorodze, T.T.; Mcgill, N.W.; Mcgrath, J.J.; Mckee, M.; Mclain, A.; Meaney, P.A.; Medina, C.; Mehndiratta, M.M.; Mekonnen, W.; Melaku, Y.A.; Meltzer, M.; Memish, Z.A.; Mensah, G.A.; Meretoja, A.; Mhimbira, F.A.; Micha, R.; Miller, T.R.; Mills, E.J.; Mitchell, P.B.; Mock, C.N.; Mohamed Ibrahim, N.; Mohammad, K.A.; Mokdad, A.H.; Mola, G.L.; Monasta, L.; Montañez Hernandez, J.C.; Montico, M.; Montine, T.J.; Mooney, M.D.; Moore, A.R.; Moradi-Lakeh, M.; Moran, A.E.; Mori, R.; Moschandreas, J.; Moturi, W.N.; Moyer, M.L.; Mozaffarian, D.; Msemburi, W.T.; Mueller, U.O.; Mukaigawara, M.; Mullany, E.C.; Murdoch, M.E.; Murray, J.; Murthy, K.S.; Naghavi, M.; Naheed, A.; Naidoo, K.S.; Naldi, L.; Nand, D.; Nangia, V.; Narayan, K.M.; Nejjari, C.; Neupane, S.P.; Newton, C.R.; Ng, M.; Ngalesoni, F.N.; Nguyen, G.; Nisar, M.I.; Nolte, S.; Norheim, O.F.; Norman, R.E.; Norrving, B.; Nyakarahuka, L.; Oh, I.H.; Ohkubo, T.; Ohno, S.L.; Olusanya, B.O.; Opio, J.N.; Ortblad, K.; Ortiz, A.; Pain, A.W.; Pandian, J.D.; Panelo, C.I.; Papachristou, C.; Park, E.K.; Park, J.H.; Patten, S.B.; Patton, G.C.; Paul, V.K.; Pavlin, B.I.; Pearce, N.; Pereira, D.M.; Perez-Padilla, R.; Perez-Ruiz, F.; Perico, N.; Pervaiz, A.; Pesudovs, K.; Peterson, C.B.; Petzold, M.; Phillips, M.R.; Phillips, B.K.; Phillips, D.E.; Piel, F.B.; Plass, D.; Poenaru, D.; Polinder, S.; Pope, D.; Popova, S.; Poulton, R.G.; Pourmalek, F.; Prabhakaran, D.; Prasad, N.M.; Pullan, R.L.; Qato, D.M.; Quistberg, D.A.; Rafay, A.; Rahimi, K.; Rahman, S.U.; Raju, M.; Rana, S.M.; Razavi, H.; Reddy, K.S.; Refaat, A.; Remuzzi, G.; Resnikoff, S.; Ribeiro, A.L.; Richardson, L.; Richardus, J.H.; Roberts, D.A.; Rojas-Rueda, D.; Ronfani, L.; Roth, G.A.; Rothenbacher, D.; Rothstein, D.H.; Rowley, J.T.; Roy, N.; Ruhago, G.M.; Saeedi, M.Y.; Saha, S.; Sahraian, M.A.; Sampson, U.K.; Sanabria, J.R.; Sandar, L.; Santos, I.S.; Satpathy, M.; Sawhney, M.; Scarborough, P.; Schneider, I.J.; Schöttker, B.; Schumacher, A.E.; Schwebel, D.C.; Scott, J.G.; Seedat, S.; Sepanlou, S.G.; Serina, P.T.; Servan-Mori, E.E.; Shackelford, K.A.; Shaheen, A.; Shahraz, S.; Shamah Levy, T.; Shangguan, S.; She, J.; Sheikhbahaei, S.; Shi, P.; Shibuya, K.; Shinohara, Y.; Shiri, R.; Shishani, K.; Shiue, I.; Shrime, M.G.; Sigfusdottir, I.D.; Silberberg, D.H.; Simard, E.P.; Sindi, S.; Singh, A.; Singh, J.A.; Singh, L.; Skirbekk, V.; Slepak, E.L.; Sliwa, K.; Soneji, S.; Søreide, K.; Soshnikov, S.; Sposato, L.A.; Sreeramareddy, C.T.; Stanaway, J.D.; Stathopoulou, V.; Stein, D.J.; Stein, M.B.; Steiner, C.; Steiner, T.J.; Stevens, A.; Stewart, A.; Stovner, L.J.; Stroumpoulis, K.; Sunguya, B.F.; Swaminathan, S.; Swaroop, M.; Sykes, B.L.; Tabb, K.M.; Takahashi, K.; Tandon, N.; Tanne, D.; Tanner, M.; Tavakkoli, M.; Taylor, H.R.; Te Ao, B.J.; Tediosi, F.; Temesgen, A.M.; Templin, T.; Ten Have, M.; Tenkorang, E.Y.; Terkawi, A.S.; Thomson, B.; Thorne-Lyman, A.L.; Thrift, A.G.; Thurston, G.D.; Tillmann, T.; Tonelli, M.; Topouzis, F.; Toyoshima, H.; Traebert, J.; Tran, B.X.; Trillini, M.; Truelsen, T.; Tsilimbaris, M.; Tuzcu, E.M.; Uchendu, U.S.; Ukwaja, K.N.; Undurraga, E.A.; Uzun, S.B.; Van Brakel, W.H.; Van De Vijver, S.; van Gool, C.H.; Van Os, J.; Vasankari, T.J.; Venketasubramanian, N.; Violante, F.S.; Vlassov, V.V.; Vollset, S.E.; Wagner, G.R.; Wagner, J.; Waller, S.G.; Wan, X.; Wang, H.; Wang, J.; Wang, L.; Warouw, T.S.; Weichenthal, S.; Weiderpass, E.; Weintraub, R.G.; Wenzhi, W.; Werdecker, A.; Westerman, R.; Whiteford, H.A.; Wilkinson, J.D.; Williams, T.N.; Wolfe, C.D.; Wolock, T.M.; Woolf, A.D.; Wulf, S.; Wurtz, B.; Xu, G.; Yan, L.L.; Yano, Y.; Ye, P.; Yentür, G.K.; Yip, P.; Yonemoto, N.; Yoon, S.J.; Younis, M.Z.; Yu, C.; Zaki, M.E.; Zhao, Y.; Zheng, Y.; Zonies, D.; Zou, X.; Salomon, J.A.; Lopez, A.D.; Vos, T. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet, 2015, 386(10009), 2145-2191.
[4]
Cosnes, J.; Gower-Rousseau, C.; Seksik, P.; Cortot, A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology, 2011, 140(6), 1785-1794.
[5]
Burisch, J.; Pedersen, N.; Čuković-Čavka, S.; Brinar, M.; Kaimakliotis, I.; Duricova, D.; Shonová, O.; Vind, I.; Avnstrøm, S.; Thorsgaard, N.; Andersen, V.; Krabbe, S.; Dahlerup, J.F.; Salupere, R.; Nielsen, K.R.; Olsen, J.; Manninen, P.; Collin, P.; Tsianos, E.V.; Katsanos, K.H.; Ladefoged, K.; Lakatos, L.; Björnsson, E.; Ragnarsson, G.; Bailey, Y.; Odes, S.; Schwartz, D.; Martinato, M.; Lupinacci, G.; Milla, M.; De Padova, A.; D’Incà, R.; Beltrami, M.; Kupcinskas, L.; Kiudelis, G.; Turcan, S.; Tighineanu, O.; Mihu, I.; Magro, F.; Barros, L.F.; Goldis, A.; Lazar, D.; Belousova, E.; Nikulina, I.; Hernandez, V.; Martinez-Ares, D.; Almer, S.; Zhulina, Y.; Halfvarson, J.; Arebi, N.; Sebastian, S.; Lakatos, P.L.; Langholz, E.; Munkholm, P. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut, 2014, 63(4), 588-597.
[6]
Molodecky, N.A.; Soon, I.S.; Rabi, D.M.; Ghali, W.A.; Ferris, M.; Chernoff, G.; Benchimol, E.I.; Panaccione, R.; Ghosh, S.; Barkema, H.W.; Kaplan, G.G. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology,2012, 142(1), 46-54, e42.
[7]
Leddin, D.; Tamim, H.; Levy, A.R. Decreasing incidence of inflammatory bowel disease in eastern Canada: a population database study. BMC Gastroenterol., 2014, 14, 140.
[8]
Molinié, F.; Gower-Rousseau, C.; Yzet, T.; Merle, V.; Grandbastien, B.; Marti, R.; Lerebours, E.; Dupas, J.L.; Colombel, J.F.; Salomez, J.L.; Cortot, A. Opposite evolution in incidence of Crohn’s disease and ulcerative colitis in Northern France (1988-1999). Gut, 2004, 53(6), 843-848.
[9]
Loftus, C.G.; Loftus, E.V., Jr; Harmsen, W.S.; Zinsmeister, A.R.; Tremaine, W.J.; Melton, L.J., III; Sandborn, W.J. Update on the incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm. Bowel Dis., 2007, 13(3), 254-261.
[10]
Burisch, J. jess, T.; Martinato, M.; Lakatos, PL. The burden of inflammatory bowel disease in Europe. J. Crohn’s Colitis, 2013, 7, 322-337.
[11]
Prideaux, L.; Kamm, M.A.; De Cruz, P.P.; Chan, F.K.; Ng, S.C. Inflammatory bowel disease in Asia: a systematic review. J. Gastroenterol. Hepatol., 2012, 27(8), 1266-1280.
[12]
Ouyang, Q.; Tandon, R.; Goh, K.L.; Ooi, C.J.; Ogata, H.; Fiocchi, C. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr. Opin. Gastroenterol., 2005, 21(4), 408-413.
[13]
Lakatos, P.L.; Fischer, S.; Lakatos, L. Is the epidemiology of inflammatory bowel disease changing in Eastern Europe? Scand. J. Gastroenterol., 2006, 41(7), 870-871.
[14]
Dubinsky, M.C.; Yang, H.; Hassard, P.V.; Seidman, E.G.; Kam, L.Y.; Abreu, M.T.; Targan, S.R.; Vasiliauskas, E.A. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology, 2002, 122(4), 904-915.
[15]
Fraser, A.G.; Orchard, T.R.; Jewell, D.P. The efficacy of azathioprine for the treatment of inflammatory bowel disease: A 30 year review. Gut, 2002, 50(4), 485-489.
[16]
McLeod, H.L.; Siva, C. The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics. Pharmacogenomics, 2002, 3(1), 89-98.
[17]
Pacifici, G.M.; Romiti, P.; Giuliani, L.; Rane, A. Thiopurine methyltransferase in humans: development and tissue distribution. Dev. Pharmacol. Ther., 1991, 17(1-2), 16-23.
[18]
Szumlanski, C.L.; Honchel, R.; Scott, M.C.; Weinshilboum, R.M. Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes. Pharmacogenetics, 1992, 2(4), 148-159.
[19]
Honchel, R.; Aksoy, I.A.; Szumlanski, C.; Wood, T.C.; Otterness, D.M.; Wieben, E.D.; Weinshilboum, R.M. Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA. Mol. Pharmacol., 1993, 43(6), 878-887.
[20]
Salavaggione, O.E.; Wang, L.; Wiepert, M.; Yee, V.C.; Weinshilboum, R.M. Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics. Pharmacogenet. Genomics, 2005, 15(11), 801-815.
[21]
Schaeffeler, E.; Zanger, U.M.; Eichelbaum, M.; Asante-Poku, S.; Shin, J.G.; Schwab, M. Highly multiplexed genotyping of thiopurine s-methyltransferase variants using MALD-TOF mass spectrometry: reliable genotyping in different ethnic groups. Clin. Chem., 2008, 54(10), 1637-1647.
[22]
McLeod, H.L.; Krynetski, E.Y.; Relling, M.V.; Evans, W.E. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia, 2000, 14(4), 567-572.
[23]
Otterness, D.; Szumlanski, C.; Lennard, L.; Klemetsdal, B.; Aarbakke, J.; Park-Hah, J.O.; Iven, H.; Schmiegelow, K.; Branum, E.; O’Brien, J.; Weinshilboum, R. Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clin. Pharmacol. Ther., 1997, 62(1), 60-73.
[24]
Hon, Y.Y.; Fessing, M.Y.; Pui, C.H.; Relling, M.V.; Krynetski, E.Y.; Evans, W.E. Polymorphism of the thiopurine S-methyltransferase gene in African-Americans. Hum. Mol. Genet., 1999, 8(2), 371-376.
[25]
Collie-Duguid, E.S.R.; Pritchard, S.C.; Powrie, R.H.; Sludden, J.; Collier, D.A.; Li, T.; McLeod, H.L. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics, 1999, 9(1), 37-42.
[26]
Otterness, D.; Szumlanski, C.; Lennard, L.; Klemetsdal, B.; Aarbakke, J.; Park-Hah, J.O.; Iven, H.; Schmiegelow, K.; Branum, E.; O’Brien, J.; Weinshilboum, R. Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms. Clin. Pharmacol. Ther., 1997, 62(1), 60-73.
[27]
Lennard, L.; Van Loon, J.A.; Weinshilboum, R.M. Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphism. Clin. Pharmacol. Ther., 1989, 46(2), 149-154.
[28]
Krynetski, E.Y.; Krynetskaia, N.F.; Yanishevski, Y.; Evans, W.E. Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase. Mol. Pharmacol., 1995, 47(6), 1141-1147.
[29]
Lennard, L.; Van Loon, J.A.; Lilleyman, J.S.; Weinshilboum, R.M. Thiopurine pharmacogenetics in leukemia: Correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations. Clin. Pharmacol. Ther., 1987, 41(1), 18-25.
[30]
Anstey, A.; Lennard, L.; Mayou, S.C.; Kirby, J.D. Pancytopenia related to azathioprine--an enzyme deficiency caused by a common genetic polymorphism: A review. J. R. Soc. Med., 1992, 85(12), 752-756.
[31]
Ansari, A.; Hassan, C.; Duley, J.; Marinaki, A.; Shobowale-Bakre, E.M.; Seed, P.; Meenan, J.; Yim, A.; Sanderson, J. Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease. Aliment. Pharmacol. Ther., 2002, 16(10), 1743-1750.
[32]
Benkov, K.; Lu, Y.; Patel, A.; Rahhal, R.; Russell, G.; Teitelbaum, J. Role of thiopurine metabolite testing and thiopurine methyltransferase determination in pediatric IBD. J. Pediatr. Gastroenterol. Nutr., 2013, 56(3), 333-340.
[33]
Wang, L.; Pelleymounter, L.; Weinshilboum, R.; Johnson, J.A.; Hebert, J.M.; Altman, R.B.; Klein, T.E. Very important pharmacogene summary: thiopurine S-methyltransferase. Pharmacogenet. Genomics, 2010, 20(6), 401-405.
[34]
Miller, S.A.; Dykes, D.D.; Polesky, H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 1988, 16(3), 1215.
[35]
Yates, C.R.; Krynetski, E.Y.; Loennechen, T.; Fessing, M.Y.; Tai, H.L.; Pui, C.H. Molecular diagnosis of thiopurine S-methyltransferase deficiency: Genetic basis for azathioprine and mercaptopurine intolerance. Ann. Intern. Med., 1997, 126, 608-614.
[36]
Zhang, J.P.; Guan, Y.Y.; Wu, J.H.; Xu, A.L.; Zhou, S.; Huang, M. Phenotyping and genotyping study of thiopurine Smethyltransferase in healthy Chinese children: a comparison of Han and Yao ethnic groups. Br. J. Clin. Pharmacol., 2004, 58, 163-168.
[37]
Oender, K.; Lanschuetzer, C.M.; Laimer, M.; Klausegger, A.; Paulweber, B.; Kofler, B.; Hintner, H.; Bauer, J.W. Introducing a fast and simple PCR-RFLP analysis for the detection of mutant thiopurine S-methyltransferase alleles TPMT*3A and TPMT*3C. J. Eur. Acad. Dermatol. Venereol., 2006, 20(4), 396-400.
[38]
Teml, A.; Schaeffeler, E.; Schwab, M. Pretreatment determination of TPMT--state of the art in clinical practice. Eur. J. Clin. Pharmacol., 2009, 65(3), 219-221.
[39]
Leung, M.; Piatkov, I.; Rochester, C.; Boyages, S.C.; Leong, R.W.L. Normal thiopurine methyltransferase phenotype testing in a Crohn disease patient with azathioprine induced myelosuppression. Intern. Med. J., 2009, 39(2), 121-126.
[40]
Laróvere, L.E.; de Kremer, R.D.; Lambooy, L.H.; De Abreu, R.A. Genetic polymorphism of thiopurine S-methyltransferase in Argentina. Ann. Clin. Biochem., 2003, 40(Pt 4), 388-393.
[41]
Sayitoglu, M.A.; Yildiz, I.; Hatirnaz, O.; Ozbek, U. Common cytochrome p4503A (CYP3A4 and CYP3A5) and thiopurine S-methyltransferase (TPMT) polymorphisms in Turkish population. Turk. J. Med. Sci., 2006, 36, 11-15.
[42]
Ameyaw, M.M.; Collie-Duguid, E.S.; Powrie, R.H.; Ofori-Adjei, D.; McLeod, H.L. Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum. Mol. Genet., 1999, 8(2), 367-370.
[43]
Dokmanovic, L.; Urosevic, J.; Janic, D.; Jovanovic, N.; Petrucev, B.; Tosic, N.; Pavlovic, S. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia. Ther. Drug Monit., 2006, 28(6), 800-806.
[44]
Isaza, C.; Henao, J.; López, A.M.; Cacabelos, R. Allelic variants of the thiopurine methyltransferase (TPMT) gene in the Colombian population. Methods Find. Exp. Clin. Pharmacol., 2003, 25(6), 423-429.
[45]
Zhang, J.P.; Guan, Y.Y.; Wu, J.H.; Jiang, W.Q.; Huang, M. Genetic polymorphism of the thiopurine S-methyltransferase of healthy Han Chinese. Ai Zheng,, 2003, 22(4), 385-388.
[46]
Hamdy, S.I.; Hiratsuka, M.; Narahara, K.; Endo, N.; El-Enany, M.; Moursi, N.; Ahmed, M.S.; Mizugaki, M. Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population. Br. J. Clin. Pharmacol., 2003, 55(6), 560-569.
[47]
Desatova, B.; Hlavaty, T.; Balakova, D.; Pav, I.; Celec, P.; Gregus, M.; Zakuciova, M.; Hlista, M.; Horakova, M.; Kadasi, L.; Huorka, M.; Batovsky, M. Prevalence of mutations in thiopurine S-methyltransferase gene among Slovak IBD patients. Bratisl. Lek Listy, 2013, 114(6), 330-332.
[48]
Takatsu, N.; Matsui, T.; Murakami, Y.; Ishihara, H.; Hisabe, T.; Nagahama, T.; Maki, S.; Beppu, T.; Takaki, Y.; Hirai, F.; Yao, K. Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease. J. Gastroenterol. Hepatol., 2009, 24(7), 1258-1264.
[49]
Gearry, R.B.; Barclay, M.L. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease. J. Gastroenterol. Hepatol., 2005, 20(8), 1149-1157.
[50]
De Vroey, B.; Colombel, J.F. IBD in 2010: optimizing treatment and minimizing adverse events. Nat. Rev. Gastroenterol. Hepatol., 2011, 8(2), 74-76.
[51]
Lennard, L. TPMT in the treatment of Crohn’s disease with azathioprine. Gut, 2002, 51(2), 143-146.
[52]
Stocco, G.; Martelossi, S.; Barabino, A.; Fontana, M.; Lionetti, P.; Decorti, G.; Malusà, N.; Bartoli, F.; Fezzi, M.; Giraldi, T.; Ventura, A. TPMT genotype and the use of thiopurines in paediatric inflammatory bowel disease. Dig. Liver Dis., 2005, 37(12), 940-945.
[53]
Rossi, A.M.; Bianchi, M.; Guarnieri, C.; Barale, R.; Pacifici, G.M. Genotype-phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects. Eur. J. Clin. Pharmacol., 2001, 57(1), 51-54.
[54]
Travis, S.P.; Stange, E.F.; Lémann, M.; Öresland, T.; Chowers, Y.; Forbes, A.; D’Haens, G.; Kitis, G.; Cortot, A.; Prantera, C.; Marteau, P.; Colombel, J.F.; Gionchetti, P.; Bouhnik, Y.; Tiret, E.; Kroesen, J.; Starlinger, M.; Mortensen, N.J. European evidence based consensus on the diagnosis and management of Crohn’s disease: current management. Gut, 2006, 55(Suppl. 1), i16-i35.
[55]
Teml, A.; Schaeffeler, E.; Herrlinger, K.R.; Klotz, U.; Schwab, M. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing. Clin. Pharmacokinet., 2007, 46(3), 187-208.
[56]
Dignass, A.; Van Assche, G.; Lindsay, J.O.; Lémann, M.; Söderholm, J.; Colombel, J.F.; Danese, S.; D’Hoore, A.; Gassull, M.; Gomollón, F.; Hommes, D.W.; Michetti, P.; O’Morain, C.; Oresland, T.; Windsor, A.; Stange, E.F.; Travis, S.P. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: Current management. J. Crohn’s Colitis, 2010, 4(1), 28-62.
[57]
Colombel, J.F.; Ferrari, N.; Debuysere, H.; Marteau, P.; Gendre, J.P.; Bonaz, B.; Soulé, J.C.; Modigliani, R.; Touze, Y.; Catala, P.; Libersa, C.; Broly, F. Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn’s disease and severe myelosuppression during azathioprine therapy. Gastroenterology, 2000, 118(6), 1025-1030.
[58]
Evans, W.E.; Horner, M.; Chu, Y.Q.; Kalwinsky, D.; Roberts, W.M. Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia. J. Pediatr., 1991, 119(6), 985-989.
[59]
Kaskas, B.A.; Louis, E.; Hindorf, U.; Schaeffeler, E.; Deflandre, J.; Graepler, F.; Schmiegelow, K.; Gregor, M.; Zanger, U.M.; Eichelbaum, M.; Schwab, M. Safe treatment of thiopurine S-methyltransferase deficient Crohn’s disease patients with azathioprine. Gut, 2003, 52(1), 140-142.
[60]
Gearry, R.B.; Barclay, M.L.; Burt, M.J.; Collett, J.A.; Chapman, B.A.; Roberts, R.L.; Kennedy, M.A. Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease. Aliment. Pharmacol. Ther., 2003, 18(4), 395-400.
[61]
Kubota, T.; Nishida, A.; Takeuchi, K.; Iida, T.; Yokota, H.; Higashi, K.; Nakahara, K.; Hanai, H.; Iga, T. Frequency distribution of thiopurine S-methyltransferase activity in red blood cells of a healthy Japanese population. Ther. Drug Monit., 2004, 26(3), 319-321.
[62]
Winter, J.W.; Gaffney, D.; Shapiro, D.; Spooner, R.J.; Marinaki, A.M.; Sanderson, J.D.; Mills, P.R. Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease. Aliment. Pharmacol. Ther., 2007, 25(9), 1069-1077.
[63]
Dong, X.W.; Zheng, Q.; Zhu, M.M.; Tong, J.L.; Ran, Z.H. Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease. World J. Gastroenterol., 2010, 16(25), 3187-3195.